EyePoint Pharmaceuticals Vs. Semtech Industry Stock Comparison

Sell

30

EYPT
EyePoint Pharmaceuticals

Last Price:

$6.26

Seasonality Move:

16.96%

Sell

47

SMTC
Semtech

Last Price:

$39.60

Seasonality Move:

6.36%

Sell

30

EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

The current EyePoint Pharmaceuticals [EYPT] share price is $6.10. The Score for EYPT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
EYPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

47

Semtech (SMTC) is a Sell

Is Semtech a Buy, Sell or Hold?

The current Semtech [SMTC] share price is $40.64. The Score for SMTC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
SMTC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

The EyePoint Pharmaceuticals share price today is $6.10

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight selling pressure.

SMTC Stock Price Chart

What is Semtech's stock price today?

The Semtech share price today is $40.64

The current trend is relatively stagnant and SMTC is experiencing selling pressure, which indicates risk of future bearish movement.

EYPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.13	Sell
Relative Strength Index (14 RSI):	40.95	Sell
Chaikin Money Flow:	-121053	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(6.01 - 6.89)	Sell
Bollinger Bands (100):	(6.44 - 9.82)	Sell

SMTC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.77	Sell
Relative Strength Index (14 RSI):	50.46	Buy
Chaikin Money Flow:	-1505033	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(34.39 - 39.33)	Buy
Bollinger Bands (100):	(40.73 - 66.49)	Sell

EYPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	6.65	Sell
20-day SMA:	6.45	Sell
50-day SMA:	7.06	Sell
200-day SMA:	8.53	Sell
8-day EMA:	6.45	Sell
20-day EMA:	6.57	Sell
50-day EMA:	7	Sell
200-day EMA:	9.18	Sell

SMTC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	37.34	Buy
20-day SMA:	36.78	Buy
50-day SMA:	51.29	Sell
200-day SMA:	45.19	Sell
8-day EMA:	38.49	Buy
20-day EMA:	39.3	Buy
50-day EMA:	46.1	Sell
200-day EMA:	45.59	Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.

Semtech Earnings Growth & SMTC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.91 per share.

EyePoint Pharmaceuticals Technical Analysis

	Mar 7	Mar 10	Mar 11	Mar 12	Mar 13	Mar 14	Mar 17	Mar 18	Mar 19	Mar 20
	Mar
	07	10	11	12	13	14	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Semtech Technical Analysis

	Mar 6	Mar 7	Mar 11	Mar 12	Mar 13	Mar 14	Mar 17	Mar 18	Mar 19	Mar 20
	Mar
	06	07	11	12	13	14	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):